Previous Article | Next Article 
Molecular and Cellular Biology, June 2001, p. 3789-3806, Vol. 21, No. 11
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.11.3789-3806.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
c-Myc Is a Critical Target for C/EBP
in
Granulopoiesis
Lisa M.
Johansen,1
Atsushi
Iwama,2
Tracey A.
Lodie,1
Koichi
Sasaki,3
Dean W.
Felsher,4
Todd R.
Golub,3 and
Daniel G.
Tenen1,*
Harvard Institutes of
Medicine1 and Dana-Farber Cancer
Institute,3 Harvard Medical School, Boston,
Massachusetts 02115; Department of Immunology, University of
Tsukuba, Tsukuba, Japan2; and
Stanford University School of Medicine, Stanford, California
04305-51154
Received 6 October 2000/Returned for modification 22 November
2000/Accepted 14 March 2001
CCAAT/enhancer binding protein
(C/EBP
) is an integral factor
in the granulocytic developmental pathway, as myeloblasts from
C/EBP
-null mice exhibit an early block in differentiation. Since
mice deficient for known C/EBP
target genes do not exhibit the same
block in granulocyte maturation, we sought to identify additional
C/EBP
target genes essential for myeloid cell development. To
identify such genes, we used both representational difference analysis
and oligonucleotide array analysis with RNA derived from a
C/EBP
-inducible myeloid cell line. From each of these independent screens, we identified c-Myc as a C/EBP
negatively regulated gene.
We mapped an E2F binding site in the c-Myc promoter as the cis-acting element critical for C/EBP
negative
regulation. The identification of c-Myc as a C/EBP
target gene is
intriguing, as it has been previously shown that down-regulation of
c-Myc can induce myeloid differentiation. Here we show that stable
expression of c-Myc from an exogenous promoter not responsive to
C/EBP
-mediated down-regulation forces myeloblasts to remain in an
undifferentiated state. Therefore, C/EBP
negative regulation of
c-Myc is critical for allowing early myeloid precursors to enter a
differentiation pathway. This is the first report to demonstrate that
C/EBP
directly affects the level of c-Myc expression and, thus, the
decision of myeloid blasts to enter into the granulocytic
differentiation pathway.
*
Corresponding author. Mailing address: Harvard
Institutes of Medicine, Room 954, 77 Ave. Louis Pasteur, Boston, MA
02115. Phone: (617) 667-5561. Fax: (617) 667-3299. E-mail:
dtenen{at}caregroup.harvard.edu.
Molecular and Cellular Biology, June 2001, p. 3789-3806, Vol. 21, No. 11
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.11.3789-3806.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Doulatov, S., Notta, F., Rice, K. L., Howell, L., Zelent, A., Licht, J. D., Dick, J. E.
(2009). PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev.
23: 2076-2087
[Abstract]
[Full Text]
-
Ho, P. A., Alonzo, T. A., Gerbing, R. B., Pollard, J., Stirewalt, D. L., Hurwitz, C., Heerema, N. A., Hirsch, B., Raimondi, S. C., Lange, B., Franklin, J. L., Radich, J. P., Meshinchi, S.
(2009). Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood
113: 6558-6566
[Abstract]
[Full Text]
-
Koschmieder, S., Halmos, B., Levantini, E., Tenen, D. G.
(2009). Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer. JCO
27: 619-628
[Abstract]
[Full Text]
-
Soliera, A. R., Lidonnici, M. R., Ferrari-Amorotti, G., Prisco, M., Zhang, Y., Martinez, R. V., Donato, N. J., Calabretta, B.
(2008). Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBP{alpha} in p210BCR/ABL-expressing cells. Blood
112: 1942-1950
[Abstract]
[Full Text]
-
Koschmieder, S., D'Alo, F., Radomska, H., Schoneich, C., Chang, J. S., Konopleva, M., Kobayashi, S., Levantini, E., Suh, N., Di Ruscio, A., Voso, M. T., Watt, J. C., Santhanam, R., Sargin, B., Kantarjian, H., Andreeff, M., Sporn, M. B., Perrotti, D., Berdel, W. E., Muller-Tidow, C., Serve, H., Tenen, D. G.
(2007). CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. Blood
110: 3695-3705
[Abstract]
[Full Text]
-
Chen-Goodspeed, M., Cheng Chi Lee,
(2007). Tumor Suppression and Circadian Function. J Biol Rhythms
22: 291-298
[Abstract]
-
Chang, J. S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A. M., Briercheck, E., Ronchetti, M., Roy, D. C., Calabretta, B., Caligiuri, M. A., Perrotti, D.
(2007). High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBP{alpha}-driven myeloid differentiation. Blood
110: 994-1003
[Abstract]
[Full Text]
-
Lee, Y.-J., Jones, L. C., Timchenko, N. A., Perrotti, D., Tenen, D. G., Kogan, S. C.
(2006). CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities. Blood
108: 2416-2419
[Abstract]
[Full Text]
-
Sato, Y., Miyake, K., Kaneoka, H., Iijima, S.
(2006). Sumoylation of CCAAT/Enhancer-binding Protein {alpha} and Its Functional Roles in Hepatocyte Differentiation. J. Biol. Chem.
281: 21629-21639
[Abstract]
[Full Text]
-
Yin, H., Glass, J.
(2006). In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage. J. Biol. Chem.
281: 11496-11505
[Abstract]
[Full Text]
-
Berberich-Siebelt, F., Berberich, I., Andrulis, M., Santner-Nanan, B., Jha, M. K., Klein-Hessling, S., Schimpl, A., Serfling, E.
(2006). SUMOylation Interferes with CCAAT/Enhancer-Binding Protein beta-Mediated c-myc Repression, but Not IL-4 Activation in T Cells.. J. Immunol.
176: 4843-4851
[Abstract]
[Full Text]
-
Radomska, H. S., Basseres, D. S., Zheng, R., Zhang, P., Dayaram, T., Yamamoto, Y., Sternberg, D. W., Lokker, N., Giese, N. A., Bohlander, S. K., Schnittger, S., Delmotte, M.-H., Davis, R. J., Small, D., Hiddemann, W., Gilliland, D. G., Tenen, D. G.
(2006). Block of C/EBP{alpha} function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. JEM
203: 371-381
[Abstract]
[Full Text]
-
Porse, B. T., Pedersen, T. A., Hasemann, M. S., Schuster, M. B., Kirstetter, P., Luedde, T., Damgaard, I., Kurz, E., Schjerling, C. K., Nerlov, C.
(2006). The Proline-Histidine-Rich CDK2/CDK4 Interaction Region of C/EBP{alpha} Is Dispensable for C/EBP{alpha}-Mediated Growth Regulation In Vivo. Mol. Cell. Biol.
26: 1028-1037
[Abstract]
[Full Text]
-
Basseres, D. S., Levantini, E., Ji, H., Monti, S., Elf, S., Dayaram, T., Fenyus, M., Kocher, O., Golub, T., Wong, K.-k., Halmos, B., Tenen, D. G.
(2006). Respiratory Failure Due to Differentiation Arrest and Expansion of Alveolar Cells following Lung-Specific Loss of the Transcription Factor C/EBP{alpha} in Mice. Mol. Cell. Biol.
26: 1109-1123
[Abstract]
[Full Text]
-
Gery, S., Gombart, A. F., Yi, W. S., Koeffler, C., Hofmann, W.-K., Koeffler, H. P.
(2005). Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood
106: 2827-2836
[Abstract]
[Full Text]
-
Porse, B. T., Bryder, D., Theilgaard-Monch, K., Hasemann, M. S., Anderson, K., Damgaard, I., Jacobsen, S. E. W., Nerlov, C.
(2005). Loss of C/EBP{alpha} cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. JEM
202: 85-96
[Abstract]
[Full Text]
-
Johnson, P. F.
(2005). Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci.
118: 2545-2555
[Abstract]
[Full Text]
-
Gery, S., Tanosaki, S., Bose, S., Bose, N., Vadgama, J., Koeffler, H. P.
(2005). Down-Regulation and Growth Inhibitory Role of C/EBP{alpha} in Breast Cancer. Clin. Cancer Res.
11: 3184-3190
[Abstract]
[Full Text]
-
Prisco, M., Maiorana, A., Guerzoni, C., Calin, G., Calabretta, B., Voit, R., Grummt, I., Baserga, R.
(2004). Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells. Mol. Cell. Biol.
24: 5421-5433
[Abstract]
[Full Text]
-
Halmos, B., Basseres, D. S., Monti, S., D'Alo, F., Dayaram, T., Ferenczi, K., Wouters, B. J., Huettner, C. S., Golub, T. R., Tenen, D. G.
(2004). A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3{beta} as a Novel Tumor Suppressor in Lung Cancer. Cancer Res.
64: 4137-4147
[Abstract]
[Full Text]
-
Wang, G.-L., Iakova, P., Wilde, M., Awad, S., Timchenko, N. A.
(2004). Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP{alpha} growth inhibitory activity. Genes Dev.
18: 912-925
[Abstract]
[Full Text]
-
Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Kohler, G., Stelljes, M., Puccetti, E., Ruthardt, M., deVos, S., Hiebert, S. W., Koeffler, H. P., Berdel, W. E., Serve, H.
(2004). Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Mol. Cell. Biol.
24: 2890-2904
[Abstract]
[Full Text]
-
Schwieger, M., Lohler, J., Fischer, M., Herwig, U., Tenen, D. G., Stocking, C.
(2004). A dominant-negative mutant of C/EBP{alpha}, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse. Blood
103: 2744-2752
[Abstract]
[Full Text]
-
Muller, C., Calkhoven, C. F., Sha, X., Leutz, A.
(2004). The CCAAT Enhancer-binding Protein {alpha} (C/EBP{alpha}) Requires a SWI/SNF Complex for Proliferation Arrest. J. Biol. Chem.
279: 7353-7358
[Abstract]
[Full Text]
-
Perrotti, D., Marcucci, G., Caligiuri, M. A.
(2004). Loss of C/EBP{alpha} and Favorable Prognosis of Acute Myeloid Leukemias: A Biological Paradox. JCO
22: 582-584
[Full Text]
-
Gery, S., Gombart, A. F., Fung, Y. K., Koeffler, H. P.
(2004). C/EBP{epsilon} interacts with retinoblastoma and E2F1 during granulopoiesis. Blood
103: 828-835
[Abstract]
[Full Text]
-
Ross, S. E., Radomska, H. S., Wu, B., Zhang, P., Winnay, J. N., Bajnok, L., Wright, W. S., Schaufele, F., Tenen, D. G., MacDougald, O. A.
(2004). Phosphorylation of C/EBP{alpha} Inhibits Granulopoiesis. Mol. Cell. Biol.
24: 675-686
[Abstract]
[Full Text]
-
Tavor, S., Park, D. J., Gery, S., Vuong, P. T., Gombart, A. F., Koeffler, H. P.
(2003). Restoration of C/EBP{alpha} Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation. J. Biol. Chem.
278: 52651-52659
[Abstract]
[Full Text]
-
McConnell, M. J., Chevallier, N., Berkofsky-Fessler, W., Giltnane, J. M., Malani, R. B., Staudt, L. M., Licht, J. D.
(2003). Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression. Mol. Cell. Biol.
23: 9375-9388
[Abstract]
[Full Text]
-
Marabese, M., Vikhanskaya, F., Rainelli, C., Sakai, T., Broggini, M.
(2003). DNA damage induces transcriptional activation of p73 by removing C-EBP{alpha} repression on E2F1. Nucleic Acids Res
31: 6624-6632
[Abstract]
[Full Text]
-
D'Alo', F., Johansen, L. M., Nelson, E. A., Radomska, H. S., Evans, E. K., Zhang, P., Nerlov, C., Tenen, D. G.
(2003). The amino terminal and E2F interaction domains are critical for C/EBP{alpha}-mediated induction of granulopoietic development of hematopoietic cells. Blood
102: 3163-3171
[Abstract]
[Full Text]
-
Wang, S. E., Wu, F. Y., Yu, Y., Hayward, G. S.
(2003). CCAAT/Enhancer-Binding Protein-{alpha} Is Induced during the Early Stages of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters. J. Virol.
77: 9590-9612
[Abstract]
[Full Text]
-
Keeshan, K., Santilli, G., Corradini, F., Perrotti, D., Calabretta, B.
(2003). Transcription activation function of C/EBP{alpha} is required for induction of granulocytic differentiation. Blood
102: 1267-1275
[Abstract]
[Full Text]
-
Rylski, M., Welch, J. J., Chen, Y.-Y., Letting, D. L., Diehl, J. A., Chodosh, L. A., Blobel, G. A., Weiss, M. J.
(2003). GATA-1-Mediated Proliferation Arrest during Erythroid Maturation. Mol. Cell. Biol.
23: 5031-5042
[Abstract]
[Full Text]
-
Weber, M., Sydlik, C., Quirling, M., Nothdurfter, C., Zwergal, A., Heiss, P., Bell, S., Neumeier, D., Ziegler-Heitbrock, H. W. L., Brand, K.
(2003). Transcriptional Inhibition of Interleukin-8 Expression in Tumor Necrosis Factor-tolerant Cells: EVIDENCE FOR INVOLVEMENT OF C/EBP{beta}. J. Biol. Chem.
278: 23586-23593
[Abstract]
[Full Text]
-
Miller, M., Shuman, J. D., Sebastian, T., Dauter, Z., Johnson, P. F.
(2003). Structural Basis for DNA Recognition by the Basic Region Leucine Zipper Transcription Factor CCAAT/Enhancer-binding Protein alpha. J. Biol. Chem.
278: 15178-15184
[Abstract]
[Full Text]
-
Mizuki, M., Schwable, J., Steur, C., Choudhary, C., Agrawal, S., Sargin, B., Steffen, B., Matsumura, I., Kanakura, Y., Bohmer, F. D., Muller-Tidow, C., Berdel, W. E., Serve, H.
(2003). Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood
101: 3164-3173
[Abstract]
[Full Text]
-
Cammenga, J., Mulloy, J. C., Berguido, F. J., MacGrogan, D., Viale, A., Nimer, S. D.
(2003). Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells. Blood
101: 2206-2214
[Abstract]
[Full Text]
-
Li, B., Yang, F.-C., Clapp, D. W., Chun, K. T.
(2003). Enforced expression of CUL-4A interferes with granulocytic differentiation and exit from the cell cycle. Blood
101: 1769-1776
[Abstract]
[Full Text]
-
Truong, B.-T. H., Lee, Y.-J., Lodie, T. A., Park, D. J., Perrotti, D., Watanabe, N., Koeffler, H. P., Nakajima, H., Tenen, D. G., Kogan, S. C.
(2003). CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood
101: 1141-1148
[Abstract]
[Full Text]
-
Strieder, V., Lutz, W.
(2003). E2F Proteins Regulate MYCN Expression in Neuroblastomas. J. Biol. Chem.
278: 2983-2989
[Abstract]
[Full Text]
-
Schuster, C., Forster, K., Dierks, H., Elsasser, A., Behre, G., Simon, N., Danhauser-Riedl, S., Hallek, M., Warmuth, M.
(2003). The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate. Blood
101: 655-663
[Abstract]
[Full Text]
-
Preudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., Fenaux, P., Dombret, H.
(2002). Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood
100: 2717-2723
[Abstract]
[Full Text]
-
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., Tenen, D. G.
(2002). Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood
100: 998-1007
[Abstract]
[Full Text]
-
Wang, Q.-f., Friedman, A. D.
(2002). CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor. Blood
99: 2776-2785
[Abstract]
[Full Text]
-
Wells, J., Graveel, C. R., Bartley, S. M., Madore, S. J., Farnham, P. J.
(2002). The identification of E2F1-specific target genes. Proc. Natl. Acad. Sci. USA
99: 3890-3895
[Abstract]
[Full Text]
-
Gombart, A. F., Hofmann, W.-K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, R. J., Asou, H., Miller, C. W., Hoelzer, D., Koeffler, H. P.
(2002). Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood
99: 1332-1340
[Abstract]
[Full Text]
-
Halmos, B., Huettner, C. S., Kocher, O., Ferenczi, K., Karp, D. D., Tenen, D. G.
(2002). Down-Regulation and Antiproliferative Role of C/EBP{alpha} in Lung Cancer. Cancer Res.
62: 528-534
[Abstract]
[Full Text]
-
Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., Farnham, P. J.
(2001). Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters. Mol. Cell. Biol.
21: 6820-6832
[Abstract]
[Full Text]